{
    "Trade/Device Name(s)": [
        "Healgen Secobarbital Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Buprenorphine Test (Strip, Cassette, Cup, Dip Card)",
        "Healgen Methadone Test (Strip, Cassette, Cup, Dip Card)"
    ],
    "Submitter Information": "HEALGEN SCIENTIFIC LLC",
    "510(k) Number": "K150791",
    "Predicate Device Reference 510(k) Number(s)": [
        "K132812"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIS",
        "DJR",
        "DJG"
    ],
    "Summary Letter Date": "March 15, 2015",
    "Summary Letter Received Date": "March 25, 2015",
    "Submission Date": "April 21, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Barbiturate test system",
        "Methadone test system",
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Secobarbital",
        "Buprenorphine",
        "Methadone"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Strip",
        "Cassette",
        "Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Competitive binding",
        "Antigen-antibody immunochemistry",
        "Lateral flow immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Strip",
        "Cassette",
        "Dip Card",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Secobarbital, Buprenorphine, and Methadone rapid lateral flow urine assays for qualitative drug detection.",
    "Indications for Use Summary": "Qualitative determination of Secobarbital (300 ng/mL), Buprenorphine (10 ng/mL), or Methadone (300 ng/mL) in human urine via immunochromatographic assay available in Strip, Cassette, Dip Card, and Cup formats for prescription and over-the-counter in vitro diagnostic use.",
    "fda_folder": "Toxicology"
}